Cindrova-Davies T
Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK.
Placenta. 2009 Mar;30 Suppl A:S55-65. doi: 10.1016/j.placenta.2008.11.020. Epub 2008 Dec 31.
Pre-eclampsia is the most important complication of human pregnancy worldwide and a major contributor to maternal and fetal morbidity and mortality. Strong evidence exists that generation of placental oxidative stress, secondary to deficient spiral artery remodelling, is a key intermediary event, triggering the secretion of a mixture of placental factors that culminate in an enhanced maternal inflammatory response. Reactive oxygen species (ROS) have been recognised as secondary messengers in intracellular signalling cascades. Experiments studying placental ischaemia-reperfusion in vitro or in vivo during labour provide strong evidence suggesting that oxidative stress and ROS production can activate downstream stress-signalling pathways, p38 and SAPK/JNK MAPK, and the pro-inflammatory NF-kappaB signalling pathway, culminating in the release of inflammatory mediators, apoptotic debris, anti-angiogenic factors and other mediators, which then stimulate a maternal inflammatory reaction that manifests in endothelial dysfunction and the symptoms of pre-eclampsia. Addition of anti-oxidants or blocking the stress or inflammatory pathways in vitro attenuates these effects and opens possibilities for therapeutic intervention.
子痫前期是全球人类妊娠最重要的并发症,也是孕产妇和胎儿发病及死亡的主要原因。有充分证据表明,继发于螺旋动脉重塑不足的胎盘氧化应激产生是一个关键的中间事件,触发胎盘因子混合物的分泌,最终导致母体炎症反应增强。活性氧(ROS)已被公认为细胞内信号级联反应中的第二信使。在分娩期间体外或体内研究胎盘缺血再灌注的实验提供了有力证据,表明氧化应激和ROS产生可激活下游应激信号通路、p38和SAPK/JNK丝裂原活化蛋白激酶(MAPK)以及促炎核因子κB信号通路,最终导致炎症介质、凋亡碎片、抗血管生成因子和其他介质的释放,进而刺激母体炎症反应,表现为内皮功能障碍和子痫前期症状。在体外添加抗氧化剂或阻断应激或炎症通路可减弱这些作用,并为治疗干预开辟了可能性。